En hypotese om forbindelsen mellem visceral lipomatose og proteasehæmmere samt lipoatrophia og nukleosid reverse transkriptasehæmmere er blevet opstillet.
A connection between visceral lipomatosis and protease inhibitors, and lipoatrophy and nucleoside reverse transcriptase inhibitors has been hypothesised.